Design of phase I and II clinical trials in cancer: a statistician's view.

(1984). Design of Phase I and II Clinical Trials in Cancer: A Statistician's View. Cancer Investigation: Vol. 2, No. 6, pp. 483-491.

[1]  Michael A. Malcolm,et al.  Computer methods for mathematical computations , 1977 .

[2]  J Whitehead,et al.  Group sequential clinical trials with triangular continuation regions. , 1983, Biometrics.

[3]  D. Pinkel.  The use of body surface area as a criterion of drug dosage in cancer chemotherapy. , 1958, Cancer research.

[4]  F. N. David,et al.  Principles and procedures of statistics. , 1961 .

[5]  T R Fleming,et al.  One-sample multiple testing procedure for phase II clinical trials. , 1982, Biometrics.

[6]  A. Guarino,et al.  Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology. , 1973, Cancer chemotherapy reports. Part 3.

[7]  S. Carter,et al.  Management of trials in the development of cancer chemotherapy. , 1978, British Journal of Cancer.

[8]  P. Lavin,et al.  Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. , 1976, Cancer treatment reports.

[9]  J. Whitehead,et al.  A FORTRAN program for the design and analysis of sequential clinical trials. , 1983, Computers and biomedical research, an international journal.

[10]  S J Pocock,et al.  Interim analyses for randomized clinical trials: the group sequential approach. , 1982, Biometrics.

[11]  E. Gehan,et al.  The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. , 1961, Journal of chronic diseases.

[12]  Christopher Jennison,et al.  Confidence Intervals for a Binomial Parameter Following a Multistage Test With Application to MIL-STD 105D and Medical Trials , 1983 .

[13]  C M Metzler,et al.  Bioavailability--a problem in equivalence. , 1974, Biometrics.

[14]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[15]  M. Schneiderman.  Mouse to man: statistical problems in bringing a drug to clinical trial , 1967 .

[16]  M Slavik,et al.  Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. , 1975, Cancer research.

[17]  David L. DeMets,et al.  Group sequential methods for clinical trials with a one-sided hypothesis , 1980 .

[18]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.

[19]  I. Tannock,et al.  Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  S. Pocock.  Group sequential methods in the design and analysis of clinical trials , 1977 .

[21]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.